The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-amino-4-fluorophenyl)-4-(1-phenylcyclopropanecarboxamido)benzamide ID: ALA4282365
PubChem CID: 145980433
Max Phase: Preclinical
Molecular Formula: C23H20FN3O2
Molecular Weight: 389.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1cc(F)ccc1NC(=O)c1ccc(NC(=O)C2(c3ccccc3)CC2)cc1
Standard InChI: InChI=1S/C23H20FN3O2/c24-17-8-11-20(19(25)14-17)27-21(28)15-6-9-18(10-7-15)26-22(29)23(12-13-23)16-4-2-1-3-5-16/h1-11,14H,12-13,25H2,(H,26,29)(H,27,28)
Standard InChI Key: SGNVQIGYVYFLHY-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
4.2964 -23.8719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8920 -23.1620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4789 -23.8693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0285 -21.9321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0273 -22.7557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7395 -23.1647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4533 -22.7552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4505 -21.9285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7377 -21.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1607 -21.5131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8741 -21.9231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1577 -20.6918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5803 -21.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2921 -21.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0019 -21.5065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9992 -20.6843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2809 -20.2785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5740 -20.6915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8632 -20.2883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7090 -20.2721 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.3152 -23.1638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6036 -22.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6043 -21.9333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1841 -22.7535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1895 -21.9312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4788 -21.5180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7657 -21.9302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7677 -22.7557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4789 -23.1611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
1 3 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
16 20 1 0
5 21 1 0
21 22 1 0
22 2 1 0
22 23 2 0
2 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.43Molecular Weight (Monoisotopic): 389.1540AlogP: 4.33#Rotatable Bonds: 5Polar Surface Area: 84.22Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.06CX Basic pKa: 2.19CX LogP: 4.09CX LogD: 4.09Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.57Np Likeness Score: -1.42
References 1. Adhikari N, Amin SA, Trivedi P, Jha T, Ghosh B.. (2018) HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches., 157 [PMID:30179749 ] [10.1016/j.ejmech.2018.08.081 ]